Weekly Winners | Kenvue, Datadog, Expedia Soar 17%; Incyte, Expeditors Surge 13%; Marriott Jumps 12%

Tiger Newspress
11/09

This week, which stocks lagged or dragged? Weekly Winners column keeps up with market trends, helping Tigers sort out the week's hottest sectors, stock winners and important news.

Below are top 10 S&P 500 stock gainers for the week ended Nov. 7:

Kimberly-Clark Agrees to Buy Tylenol Owner Kenvue in $48.7 Billion Deal, Creating Consumer Staples Giant

Kimberly-Clark announced Monday it’s struck an agreement to buy Kenvue Inc in a deal valued at $48.7 billion that would create a consumer staples giant.

The deal is a combination of cash and stock and totals about $40 billion on an equity basis, excluding the impact of debt. Shares of Kenvue surged 12% Monday, while Kimberly-Clark stock fell 14%.

The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol. It would include 10 billion-dollar brands, the companies said in a news release. The acquisition would be one of the largest on Wall Street this year.

Datadog's Stock Soars on Revenue Beat, Posts Second-Best Day Ever

Datadog shares jumped 23% on Thursday after the software company reported third-quarter revenue that topped Wall Street estimates and issued a strong forecast for the fourth quarter.

The stock had its second-best day ever, behind only November 2023, when shares rose 28%.

The company reported revenue of $885.7 million, which was up 28% year over year, and topped the $852.8 million expected by LSEG analysts.

Expedia Stock Jumps. High Travel Demand Powers Stronger-Than-Expected Q3 Results

Expedia stock jumped late Thursday after the online travel booking company posted a third-quarter earnings beat and offered a strong sales forecast for the final three months of the year.

Expedia said that it earned an adjusted $7.57 per share for the September-ended quarter, up 23% from a year earlier. That beat the $6.97 per share that analysts polled by FactSet were forecasting. Sales increased 9% to $4.41 billion compared to analyst estimates of $4.28 billion.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10